Management of untreated advanced stage follicular lymphoma: Role of patient discernment

Jayadev Manikkam Umakanthan, Matthew A Lunning

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Follicular lymphoma is the most common indolent non-Hodgkin lymphoma. Advanced stage disease is common at diagnosis. The timing of treatment for follicular lymphoma is best approached by considering the combination of presence or absence of symptoms along with estimation of tumor burden. Upfront treatment strategies should take into initial presentation variables, pace of disease progression and goals of care after discussion with the patient. Treatment approaches remain diverse and patient discernment is paramount.

Original languageEnglish (US)
Pages (from-to)23-30
Number of pages8
JournalBest Practice and Research: Clinical Haematology
Volume31
Issue number1
DOIs
StatePublished - Mar 2018

Fingerprint

Follicular Lymphoma
Patient Care Planning
Tumors
Tumor Burden
Non-Hodgkin's Lymphoma
Disease Progression
Therapeutics

Keywords

  • Advanced stage
  • Follicular Lymphoma
  • Treatment

ASJC Scopus subject areas

  • Oncology
  • Clinical Biochemistry

Cite this

Management of untreated advanced stage follicular lymphoma : Role of patient discernment. / Umakanthan, Jayadev Manikkam; Lunning, Matthew A.

In: Best Practice and Research: Clinical Haematology, Vol. 31, No. 1, 03.2018, p. 23-30.

Research output: Contribution to journalReview article

@article{45fbda3ab94f4bb9957649443d43ab94,
title = "Management of untreated advanced stage follicular lymphoma: Role of patient discernment",
abstract = "Follicular lymphoma is the most common indolent non-Hodgkin lymphoma. Advanced stage disease is common at diagnosis. The timing of treatment for follicular lymphoma is best approached by considering the combination of presence or absence of symptoms along with estimation of tumor burden. Upfront treatment strategies should take into initial presentation variables, pace of disease progression and goals of care after discussion with the patient. Treatment approaches remain diverse and patient discernment is paramount.",
keywords = "Advanced stage, Follicular Lymphoma, Treatment",
author = "Umakanthan, {Jayadev Manikkam} and Lunning, {Matthew A}",
year = "2018",
month = "3",
doi = "10.1016/j.beha.2017.10.004",
language = "English (US)",
volume = "31",
pages = "23--30",
journal = "Best Practice and Research in Clinical Haematology",
issn = "1521-6926",
publisher = "Bailliere Tindall Ltd",
number = "1",

}

TY - JOUR

T1 - Management of untreated advanced stage follicular lymphoma

T2 - Role of patient discernment

AU - Umakanthan, Jayadev Manikkam

AU - Lunning, Matthew A

PY - 2018/3

Y1 - 2018/3

N2 - Follicular lymphoma is the most common indolent non-Hodgkin lymphoma. Advanced stage disease is common at diagnosis. The timing of treatment for follicular lymphoma is best approached by considering the combination of presence or absence of symptoms along with estimation of tumor burden. Upfront treatment strategies should take into initial presentation variables, pace of disease progression and goals of care after discussion with the patient. Treatment approaches remain diverse and patient discernment is paramount.

AB - Follicular lymphoma is the most common indolent non-Hodgkin lymphoma. Advanced stage disease is common at diagnosis. The timing of treatment for follicular lymphoma is best approached by considering the combination of presence or absence of symptoms along with estimation of tumor burden. Upfront treatment strategies should take into initial presentation variables, pace of disease progression and goals of care after discussion with the patient. Treatment approaches remain diverse and patient discernment is paramount.

KW - Advanced stage

KW - Follicular Lymphoma

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=85034454413&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034454413&partnerID=8YFLogxK

U2 - 10.1016/j.beha.2017.10.004

DO - 10.1016/j.beha.2017.10.004

M3 - Review article

C2 - 29452663

AN - SCOPUS:85034454413

VL - 31

SP - 23

EP - 30

JO - Best Practice and Research in Clinical Haematology

JF - Best Practice and Research in Clinical Haematology

SN - 1521-6926

IS - 1

ER -